HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit an electronic Letter to the Editor about this paper View responses Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (20) Citing Articles via Google Scholar Google Scholar Articles by Sacks, D. B. Search for Related Content PubMed PubMed Citation Articles by Sacks, D. B. Related Collections Current Issues in Laboratory Medicine Proteomics and Protein Markers Endocrinology and Metabolism

Global Harmonization of Hemoglobin A1c

Department of Pathology, Brigham and Women’s Hospital and Harvard Medical School, 75 Francis St., Thorn 530, Boston, MA 02115, Fax 617-278-6921,

E-mail dsacks@rics.bwh.harvard.edu

The first 300 words of the full text of this article appear below.

Measurement of glycohemoglobin (GHb) is widely used in patients with diabetes mellitus as a monitor of long-term glycemic control (1)(2)(3). In addition, prospective randomized clinical trials, most notably the Diabetes Control and Complications Trial (DCCT) and the United Kingdom Prospective Diabetes Study (UKPDS), have demonstrated that GHb is a measure of the risk for the development of diabetes complications (4)(5). GHb is therefore an integral component of the management of patients with diabetes.

GHb comprises several different hemoglobin-glucose adducts, including hemoglobin A1a (HbA1a), HbA1b, and HbA1c. More than 30 different methods are commercially available to measure GHb. Together these factors have led to considerable variation in reference intervals and results reported by different laboratories. When the DCCT was published in 1993, the lack of standardization of GHb methods produced very wide variability among methods, with values ranging from 4.0% to 8.1% on the same blood sample (6). In the United States, the NGSP (previously known as the National Glycohemoglobin Standardization Program) has reduced interlaboratory variation (7). Using a standardization process based on the DCCT reference method, the NGSP has promoted a dramatic improvement in comparability of GHb values among laboratories (3). Data from the 2003 GH2 survey from the College of American Pathologists indicated that 98% of participating laboratories use NGSP-certified methods and report results as HbA1c or HbA1c equivalents (3). Analogous standardization programs in Sweden and Japan (8)(9), established to harmonize GHb results, have also reduced variability among GHb results. More recently, the IFCC Working Group on HbA1c Standardization prepared primary reference materials of pure HbA1c and HbA0 and developed a reference method for HbA1c (10). They defined HbA1c as the stable adduct of glucose . . . [Full Text of this Article]

The following articles in journals at HighWire Press have cited this article:

				N. Iqbal, C. Morgan, H. Maksoud, and I. Idris Improving patients' knowledge on the relationship between HbA1c and mean plasma glucose improves glycaemic control among persons with poorly controlled diabetes Ann Clin Biochem, September 1, 2008; 45(5): 504 - 507. [Abstract] [Full Text] [PDF]

				A H Berg and D B Sacks Haemoglobin A1c analysis in the management of patients with diabetes: from chaos to harmony J. Clin. Pathol., September 1, 2008; 61(9): 983 - 987. [Abstract] [Full Text] [PDF]

				D. M. Nathan, J. Kuenen, R. Borg, H. Zheng, D. Schoenfeld, R. J. Heine, and for the A1c-Derived Average Glucose (ADAG) Study G Translating the A1C Assay Into Estimated Average Glucose Values Diabetes Care, August 1, 2008; 31(8): 1473 - 1478. [Abstract] [Full Text] [PDF]

				C. D. Saudek, W. H. Herman, D. B. Sacks, R. M. Bergenstal, D. Edelman, and M. B. Davidson A New Look at Screening and Diagnosing Diabetes Mellitus J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2447 - 2453. [Abstract] [Full Text] [PDF]

				E. S. Kilpatrick, A. S. Rigby, and S. L. Atkin Variability in the Relationship between Mean Plasma Glucose and HbA1c: Implications for the Assessment of Glycemic Control Clin. Chem., May 1, 2007; 53(5): 897 - 901. [Abstract] [Full Text] [PDF]

				S. Kreimer Inflammation Raises Risk of Diabetes, CVD DOC News, April 1, 2007; 4(4): 8 - 8. [Full Text]

				G. L. Hortin A New Era in Protein Quantification in Clinical Laboratories: Application of Liquid Chromatography-Tandem Mass Spectrometry Clin. Chem., April 1, 2007; 53(4): 543 - 544. [Full Text] [PDF]

				C. D. Saudek, R. L. Derr, and R. R. Kalyani Assessing Glycemia in Diabetes Using Self-monitoring Blood Glucose and Hemoglobin A1c JAMA, April 12, 2006; 295(14): 1688 - 1697. [Abstract] [Full Text] [PDF]

eLetters: